Categories
CBE Obesity

Flashcards: Epidemiology of Adult Obesity

The Core Paradigm: Obesity as a Disease

“Obesity is a complex chronic disease in which abnormal or excess body fat (adiposity) impairs health, increases the risk of long-term medical complications, and reduces lifespan.”

  • Recognition: Healthcare providers should treat obesity as a chronic disease rather than a simple lifestyle choice.

  • Etiology: Its causes are complex, involving genetics, socio-economic status, and environmental factors that extend far beyond “calories in vs. calories out.”

  • Weight Bias: Stigma and discrimination are pervasive in healthcare and significantly impact patient wellbeing and treatment outcomes.

Statistical Snapshot: Canada (1985–2016)

The prevalence of obesity in Canada has risen dramatically over the last three decades.

  • The Three-Fold Increase: Since 1985, the prevalence of adult obesity has tripled.

  • Current Impact: As of 2016, obesity affects approximately 26.4% (8.3 million) of Canadian adults.

  • The Overweight Gap: An additional 34% of adults (10.6 million) are classified as overweight.

  • The Severe Surge: Severe obesity () is the fastest-growing subgroup, increasing by 455% since 1985.

  • Economic Burden: In 2010, the total cost of obesity to the Canadian economy was estimated at $7.1 billion.

Clinical Classifications & Assessment

1. Body Mass Index (BMI)

BMI is calculated as weight () divided by height squared ().

ClassificationBMI Range (kg/m2)Health Risk
Overweight25.0 – 29.9

Increased

Obesity Class I30.0 – 34.9

High

Obesity Class II35.0 – 39.9

Very High

Obesity Class III≥ 40.0

Extremely High

Clinical Pearl: BMI should not be used in isolation; it must be paired with other clinical assessment tools.

2. Abdominal Obesity (Waist Circumference)

Abdominal adiposity is often a more significant predictor of health risk than BMI alone.

  • Men: Increased risk at (40 inches).

  • Women: Increased risk at (35 inches).

  • Trend: Average waist circumference has increased by 6.5 cm for men and 10.6 cm for women over recent decades.

3. Edmonton Obesity Staging System (EOSS)

  • A five-point system (0–4) that assesses comorbidity and functional status.

  • It is a better predictor of mortality than BMI or waist circumference alone.

Complications & Impact

Obesity is a major driver of premature morbidity and mortality in Canada.

  • Life Expectancy: Obesity can reduce lifespan by 6 to 14 years.

  • Chronic Disease: Increases risk for Type 2 diabetes, heart disease, stroke, and non-alcoholic fatty liver disease.

  • Cancer: Approximately 20% of all cancers are attributed to obesity.

  • Mental Health: Individuals with obesity are twice as likely to be diagnosed with a mood disorder.

  • Quality of Life: Reduced mobility, chronic pain (osteoarthritis), and mental health strain significantly lower health-related quality of life.

 

Categories
CBE Obesity

Practice Exam: Epidemiology of Adult Obesity (Chapter 2)

Chapter Overview

Obesity is a complex, chronic disease characterized by abnormal or excess body fat (adiposity) that impairs health and reduces life expectancy. In Canada, the prevalence of obesity has risen dramatically, increasing three-fold since 1985 and affecting approximately 26.4% of the adult population.

For the Certified Bariatric Educator (CBE) exam, understanding these epidemiological trends is essential for identifying high-risk populations and recognizing the significant humanistic and economic burden this disease places on the Canadian healthcare system.

 

Key Learning Objectives

This practice exam tests your mastery of the following core epidemiological concepts:

  • Disease Definition: Recognizing obesity as a progressive chronic disease rather than just a BMI measurement.

  • Prevalence & Trends: Identifying the disproportionate growth of severe obesity (BMI 35 ) and the regional variations across Canada.

  • Assessment Tools: Understanding the clinical utility of BMI, waist circumference, and the Edmonton Obesity Staging System (EOSS) in predicting mortality and health risk.

  • Comorbidities: Linking obesity to increased risks of Type 2 diabetes, cardiovascular disease, and several types of cancer.

  • Social Determinants: Exploring how factors like ethnicity, socio-economic status, and immigration influence obesity risk.

Exam Preparation Notes

Pay close attention to the limitations of BMI as a solo diagnostic tool. The CBE exam emphasizes that while BMI is useful for population-level screening, individual health assessment must include metabolic and functional indicators. Additionally, be prepared to answer questions regarding the shifting “obesity phenotype,” where increases in abdominal adiposity are outpacing increases in BMI.

 

1. Obesity is associated with a nearly three-fold increased risk of which condition?

2. Data from the Canadian Health Measures Survey indicates that immigrants compared to non-immigrants:

3. A public health official is developing an obesity prevention strategy. Based on the guidelines’ recommendations, which approach is most appropriate?

4. The concept of ‘metabolically healthy obesity’ is discussed in the guidelines. Healthcare providers should understand that:

5. According to Canadian data, which geographic region has the highest prevalence of obesity?

6. Which obesity subgroup has increased disproportionately compared to other obesity classes in Canada since 1985?

7. What percentage of all cancers can be attributed to obesity, independent of diet?

8. The guidelines identify that differences in obesity prevalence across geographical regions in Canada are not entirely predicted by income, education, and health behaviour factors. This points to:

9. According to the Canadian Adult Obesity Clinical Practice Guidelines, obesity is defined as:

10. A person from South Asia descent has a BMI of 26 kg/m². According to the guidelines, which statement about this patient’s health risk is most accurate?

11. According to the guidelines, in adults affected by obesity, what percentage have a waist circumference that places them at increased health risk?

12. A person taking medication for depression, hypertension, and diabetes is gaining weight. The guidelines suggest this may be because:

13. Each 5 kg/m² increase in BMI above 25 kg/m² is associated with what increased risk of all-cause mortality?

14. According to the guidelines, obesity can reduce life expectancy by:

15. When discussing obesity contributors with a patient, which statement best reflects the guidelines’ perspective?

16. What BMI threshold defines obesity in adults?

17. What are the waist circumference threshold cut-offs used to assess increased health risk?

18. Based on ethnicity-specific data in the guidelines, which statement best reflects current understanding?

19. Since 1985, by what percentage has the prevalence of obesity increased in Canada when using measured heights and weights?

20. A 14-year-old boy presents with a BMI indicating obesity. According to the epidemiological data in the guidelines, this finding:

21. The guidelines note that while obesity rates have increased over the last three decades, population-level survey data show that caloric intake has decreased and leisure-time physical activity has increased. This finding suggests:

22. The guidelines recommend that healthcare providers use BMI in conjunction with other screening and assessment tools. The Edmonton Obesity Staging System (EOSS) is highlighted because it:

23. The guidelines describe a ‘paradoxical situation’ regarding obesity treatment. This refers to:

24. The guidelines describe temporal changes in the obesity phenotype based on waist circumference data. This observation is particularly concerning because:

25. A healthcare provider is explaining why BMI alone may not predict individual health risk. According to the guidelines, the key reason is:

26. A healthcare provider is assessing a 50-year-old woman with a BMI of 29 kg/m² and a waist circumference of 95 cm. Based on the guidelines, this patient:

27. The guidelines indicate that individuals living with obesity are how many times more likely to be diagnosed with a mood disorder compared to individuals without obesity?

28. According to the guidelines, the relationship between socioeconomic status and obesity in Canadian adults:

29. A 45-year-old man has a BMI of 32 kg/m² but no metabolic abnormalities and maintains regular physical activity. According to the guidelines, this individual would be classified as:

30. The Edmonton Obesity Staging System (EOSS) is best described as:

31. When using self-reported versus measured height and weight data to determine obesity prevalence, the guidelines indicate:


 

Categories
Uncategorized

Study Guide: Epidemiology of Adult Obesity (Chapter 2)

I. Defining Obesity as a Chronic Disease

Obesity is recognized as a complex chronic disease. It is characterized by abnormal or excess body fat (adiposity) that impairs health, increases the risk of long-term medical complications, and reduces lifespan.

Key Measurements and Classifications

  • Body Mass Index (BMI): Calculated as weight (kg) divided by height squared ().

    • Overweight: BMI .

    • Obesity: .

    • Class I: BMI .

    • Class II: BMI .

    • Class III: .

    • Severe Obesity: Defined as a (includes Class II and III).

  • Waist Circumference (WC): A proxy for abdominal adiposity. Thresholds for increased health risk:

    • Men: (40 inches).

    • Women: (35 inches).

  • Edmonton Obesity Staging System (EOSS): A five-point system (0–4) that examines comorbidity and functional status. It predicts mortality independent of BMI and is a valuable clinical screening tool.

II. Canadian Epidemiological Trends

The prevalence of obesity in Canada has risen dramatically over the last 30 years.

  • Three-fold Increase: Since 1985, the prevalence of adult obesity has increased by 300%.

  • Current Impact: In 2016, obesity affected 26.4% (8.3 million) of Canadian adults.

  • Severe Obesity Growth: This is the fastest-growing subgroup, increasing 455% since 1985.

  • Abdominal Obesity: Measures of waist circumference are increasing more pronouncedly than BMI trends, which is concerning because it is associated with higher health risks.

  • Regional Variation: Obesity prevalence is highest in the Atlantic Provinces and lowest in British Columbia and Quebec.

III. Health Consequences and Risks

Obesity reduces life expectancy by 6 to 14 years.

1. Medical Complications

  • Cardiovascular: Increased risk of heart disease, stroke, and hypertension.

  • Metabolic: Higher risk of Type 2 diabetes, non-alcoholic fatty liver disease, gallbladder disease, and gout.

  • Cancer: Roughly 20% of all cancers are attributed to obesity. It specifically increases the risk of colon, kidney, pancreatic, post-menopausal breast, and endometrial cancers.

  • Mechanical: A nearly three-fold increase in the risk of osteoarthritis and impaired mobility.

2. Psychosocial and Mental Health

  • Individuals with obesity are twice as likely to be diagnosed with a mood disorder.

  • Weight bias, stigma, and discrimination are pervasive in the healthcare system, leading to health inequalities and avoidance of care.

IV. Complex Causes and Contributors

Obesity is not simply a matter of individual choice or “calories in vs. calories out”.

  • Environmental & Energy Balance: While calorie intake has decreased and leisure physical activity has increased in Canada, other factors promote weight gain. These include chronic stress, insufficient sleep, and “energy-saving conveniences” (cars, remotes).

  • Iatrogenic Factors: Many medications used to treat obesity-related comorbidities (depression, hypertension, diabetes) actually promote weight gain.

  • Socio-Cultural Factors: * Indigenous Populations: On-reserve First Nations adults report higher obesity rates (36%) than Inuit or Métis populations.

    • Income & Sex: Income and education are inversely associated with obesity in women, but income shows a positive relationship with obesity in men.

    • Ethnicity: South Asian and Chinese populations have lower obesity rates than white populations, but they face increased cardiometabolic risk at lower BMIs.

Clinical Pearl: Do not rely solely on BMI to predict health risk. Some individuals with elevated BMI are “metabolically healthy,” while others with lower BMIs (particularly in certain ethnic groups) may be at high risk.

Reference: 

Twells LK, Janssen I, Kuk JL. Canadian Adult Obesity Clinical Practice Guidelines: Epidemiology of Adult Obesity. August 4, 2020. Accessed August 4, 2020. https://obesitycanada.ca/epidemiology/
Categories
CBE Obesity

Flashcards: Reducing Weight Bias in Obesity Management, Practice, & Policy (Chapter 1)

Core Concepts and Definitions

The terms weight bias, stigma, and discrimination represent a continuum of negative attitudes and behaviors:

  • Weight Bias: Negative weight-related attitudes, beliefs, and assumptions held about people living in large bodies. It can be explicit (overtly negative attitudes like assuming someone is “lazy”), implicit (unconscious negative attitudes), or internalized (self-directed bias).

  • Weight Stigma: The manifestation of bias through harmful social stereotypes, such as assuming a patient will be non-compliant with medical advice.

  • Weight Discrimination: The unjust treatment of individuals because of their weight, such as a healthcare provider spending less time with a patient or providing less emotional rapport.

Why It Matters: Clinical Consequences

Weight bias and discrimination are not just social issues; they are significant hurdles to effective healthcare and contribute to increased morbidity and mortality:

  • Physical Health: Discrimination is associated with increased chronic stress, higher cortisol levels, and oxidative stress independent of adiposity levels. It can lead to a 60% increase in mortality risk.

  • Mental Health: Targets of weight bias often experience psychological distress, anxiety, depression, and body image disturbance.

  • Healthcare Engagement: Patients experiencing bias may delay or forgo essential preventive care (e.g., cancer screenings) for fear of disrespectful treatment. They may also engage in “doctor shopping” to find respectful providers.

The Guiding Principles for Professionals

To improve patient outcomes, healthcare providers must transition from a weight-centric to a health-centric model:

  • Self-Assessment: Providers should assess their own attitudes and beliefs using tools like the Implicit Association Test to understand how they might influence care.

  • Clinical Environment: Ensure the physical space is accessible and safe with properly sized equipment (e.g., large blood pressure cuffs, gowns, and chairs) ready before the patient arrives.

  • Communication: Always ask permission before weighing a patient and do so in a private area. Avoid judgmental words and making assumptions that every ailment is related to the patient’s weight.

  • Language: Use people-first language (e.g., “patient with obesity” instead of “obese patient”) to acknowledge the individual before the disease.

Key Takeaways for Policy and Practice

  • Weight is Not a Behaviour: Policy makers and clinicians should avoid making weight the primary target for behavior change; instead, focus on improving health and quality of life.

  • Complexity of Obesity: Recognize obesity as a complex chronic disease driven by biological, genetic, and environmental factors, rather than a matter of simple personal responsibility.

  • Address Internalized Bias: Providers should assess patients for self-stigma and self-blame, which can be addressed through behavioral interventions like Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT).

Categories
CBE Obesity

Practice Exam: Reducing Weight Bias in Obesity Management, Practice, & Policy

CBE Exam Preparation: Reducing Weight Bias, Stigma, and Discrimination

Core Concepts and Definitions

The terms weight bias, stigma, and discrimination represent a continuum of negative attitudes and behaviors:

  • Weight Bias: Negative weight-related attitudes, beliefs, and assumptions held about people living in large bodies. It can be explicit (overtly negative attitudes like assuming someone is “lazy”), implicit (unconscious negative attitudes), or internalized (self-directed bias).

  • Weight Stigma: The manifestation of bias through harmful social stereotypes, such as assuming a patient will be non-compliant with medical advice.

  • Weight Discrimination: The unjust treatment of individuals because of their weight, such as a healthcare provider spending less time with a patient or providing less emotional rapport.

Why It Matters: Clinical Consequences

Weight bias and discrimination are not just social issues; they are significant hurdles to effective healthcare and contribute to increased morbidity and mortality:

  • Physical Health: Discrimination is associated with increased chronic stress, higher cortisol levels, and oxidative stress independent of adiposity levels. It can lead to a 60% increase in mortality risk.

  • Mental Health: Targets of weight bias often experience psychological distress, anxiety, depression, and body image disturbance.

  • Healthcare Engagement: Patients experiencing bias may delay or forgo essential preventive care (e.g., cancer screenings) for fear of disrespectful treatment. They may also engage in “doctor shopping” to find respectful providers.

The Guiding Principles for Professionals

To improve patient outcomes, healthcare providers must transition from a weight-centric to a health-centric model:

  • Self-Assessment: Providers should assess their own attitudes and beliefs using tools like the Implicit Association Test to understand how they might influence care.

  • Clinical Environment: Ensure the physical space is accessible and safe with properly sized equipment (e.g., large blood pressure cuffs, gowns, and chairs) ready before the patient arrives.

  • Communication: Always ask permission before weighing a patient and do so in a private area. Avoid judgmental words and making assumptions that every ailment is related to the patient’s weight.

  • Language: Use people-first language (e.g., “patient with obesity” instead of “obese patient”) to acknowledge the individual before the disease.

Key Takeaways for Policy and Practice

  • Weight is Not a Behaviour: Policy makers and clinicians should avoid making weight the primary target for behavior change; instead, focus on improving health and quality of life.

  • Complexity of Obesity: Recognize obesity as a complex chronic disease driven by biological, genetic, and environmental factors, rather than a matter of simple personal responsibility.

  • Address Internalized Bias: Providers should assess patients for self-stigma and self-blame, which can be addressed through behavioral interventions like Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT).

Practice Exam Questions on this Chapter

Please go to Practice Exam: Reducing Weight Bias in Obesity Management, Practice, & Policy to view this quiz
Categories
CBE Obesity

Study Guide: Reducing Weight Bias in Obesity Management, Practice, & Policy (Chapter 1)

Overview of Key Constructs

The terms weight bias, stigma, and discrimination reflect a continuum of negative weight-related experiences:

  • Weight Bias: Negative attitudes, beliefs, and assumptions about people living in large bodies.

    • Explicit Bias: Overtly negative attitudes (e.g., assuming someone is “lazy” or “lacks willpower”).

    • Implicit Bias: Unconscious negative attitudes that shape how people view and treat others.

    • Internalized Bias (Self-directed): The extent to which individuals with obesity believe negative stereotypes about themselves.

  • Weight Stigma: The manifestation of bias through harmful social stereotypes.

  • Weight Discrimination: Unjust treatment based on weight, such as spending less time with a patient or providing lower-quality care.

Key Recommendations for Healthcare Providers

RecommendationStrength of Evidence

Assess your own attitudes and beliefs regarding obesity and how they may influence care.

 

 

Level 1a; Grade A

Avoid using judgmental words when working with patients.

 

 

Level 1a; Grade A

Recognize that internalized weight bias affects behavioral and health outcomes.

 

 

Level 2a; Grade B

Avoid using judgmental images and practices.

 

 

Level 2b/2a; Grade B

Avoid assuming a patient’s ailment is automatically related to their body weight.

 

 

Level 3; Grade C

Impact and Consequences

Physical & Mental Health

  • Physiological Stress: Stigma is associated with increased chronic stress, higher cortisol levels, and oxidative stress.

  • Mortality Risk: Perceiving weight discrimination is associated with a 60% increase in mortality risk, a factor comparable to smoking history.

  • Mental Health: Experiences of bias are linked to psychological distress, anxiety, depression, and body image disturbance.

  • Behavioral Effects: Bias can lead to exercise avoidance, binge eating, and medication non-adherence.

Barriers to Healthcare Engagement

  • Avoidance of Care: Patients may delay or forgo essential screenings (e.g., cancer screening) due to fear of disrespectful treatment.

  • Environment: Inaccessible clinical spaces (e.g., small chairs, gowns, or blood pressure cuffs) contribute to patients feeling unwelcome.

  • Communication: Patients often report patronizing treatment or feeling that providers blame all health issues on weight.

Strategies for Practice Improvement

Reducing Bias in Clinical Settings

  • Reflective Practice: Use tools like the Implicit Association Test to identify personal biases.

  • Clinical Environment: Ensure private weighing areas, ask permission before weighing, and provide properly sized equipment.

  • Patient Empowerment: Assess for internalized bias using sensitive questioning (e.g., “How does your weight affect your perception of yourself?”).

  • Evidence-Based Interventions: Incorporate principles of Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) to address self-stigma.

Public Health & Policy Shifts

  • Change the Narrative: Move away from “personal responsibility” and “healthy behaviors = weight change” toward recognizing obesity as a complex chronic disease.

  • Do No Harm: Avoid shaming, as it does not change behavior and can actually increase unhealthy habits.

  • Focus on Quality of Life: Evaluate programs based on health outcomes and quality of life for people of all sizes rather than just BMI.

Reference:

Kirk SFL, Ramos Salas X, Alberga A, Russell-Mayhew S. Canadian Adult Obesity Clinical Practice Guideline: Reducing Weight Bias in Obesity Management, Practice & Policy. Published online August 4, 2020. Accessed August 4, 2020. http://obesitycanada.ca/wp-content/uploads/2020/08/1-Reducing-Weight-Bias-v5_FINAL.pdf
Categories
CDE Diabetes

Flashcards: FIT Canada Recommendations for Injection Technique

The Forum for Injection Technique (FIT) Canada emphasizes that the effectiveness of insulin therapy is largely dependent on how it is delivered. Poor technique can lead to erratic absorption, unexplained hypoglycemia, and long-term complications. These flashcards are designed to help pharmacists and healthcare professionals memorize the 4th Edition Recommendations regarding needle length selection, the prevention of lipohypertrophy, and proper site rotation.

Key Topics Covered:

  • Needle Selection: Memorizing the evidence that 4 mm pen needles are recommended for all adults and children, regardless of BMI, to minimize the risk of intramuscular (IM) injection.

  • Lipohypertrophy (LH): Identifying the impact of “lumpy” injection sites on glycemic control—specifically that injecting into LH can reduce insulin absorption by up to 25% and cause significant variability.

  • Site Rotation: Applying structured rotation principles, such as spacing injections at least 1 cm (approx. one finger width) apart and utilizing divided zones to preserve tissue health.

  • Single Use: Reinforcing the strict rule that needles and syringes are single-use devices and must be discarded immediately to prevent tip deformation and infection.

  • Troubleshooting: Recognizing that unexplained hypoglycemia or hyperglycemia is often a sign of injection site complications rather than a need for dose adjustment.

Categories
CDE Diabetes

Practice Exam: FIT Canada Recommendations for Injection Technique

The efficacy of insulin therapy is only as good as the technique used to deliver it. The Forum for Injection Technique (FIT) Canada Recommendations emphasize that correct injection technique is just as critical as the type and dose of insulin prescribed. Poor technique can lead to unexplained hypoglycemia, glycemic variability, and long-term complications.

This practice exam tests your ability to apply the “Golden Rules” of injection, manage injection site complications like lipohypertrophy, and select the appropriate delivery devices for patients of all body types.

Key Concepts Covered in This Exam:

  • Needle Selection: Understanding the evidence supporting the use of 4 mm pen needles as the safest and most effective option for all adults and children, regardless of BMI, to avoid intramuscular (IM) injections.

  • Lipohypertrophy (LH): Mastering the detection and management of “lumpy” injection sites, acknowledging that injecting into LH can reduce insulin absorption by up to 25% and cause erratic glucose levels.

  • Structured Rotation: Applying correct rotation principles—spacing injections at least 1 cm (approx. width of a finger) apart and utilizing divided zones—to preserve tissue health.

  • Single Use: Reinforcing the strict recommendation that needles and syringes are single-use devices and must be discarded immediately to prevent tip deformation, infection, and lipohypertrophy.

  • Psychological Barriers: Addressing patient fears and anxiety regarding injections to improve adherence and comfort.

Please go to Practice Exam: FIT Canada Recommendations for Injection Technique to view this quiz

Categories
CDE Diabetes

Study Guide: FIT Recommendations for Best Practice in Injection Technique

1. Core Concepts & Goals

  • Objective: To ensure the correct dose of medication is delivered to the correct injection site using proper technique to achieve optimal health outcomes.

  • Golden Rule: Insulin and GLP-1 receptor agonists should be injected into the subcutaneous tissue (fat), avoiding intramuscular (IM) injection.

  • Primary Complication: Lipohypertrophy (rubbery lesions) is the most common complication and leads to glycemic variability and unexplained hypoglycemia.

2. Device Selection & Needle Length

Pen Needles vs. Syringes

  • Needle Length Standard: 4-mm pen needles are suitable for all patients regardless of BMI (Body Mass Index).

    • They reduce the risk of intramuscular (IM) injection compared to longer needles.

    • They provide equivalent glycemic control to 8-mm or 12-mm needles even in patients with obesity.

  • Syringes: The shortest available syringe needle is currently 6-mm.

  • Not Recommended: 12-mm or 12.7-mm needles are generally not recommended due to high IM risk.

Safety & Hygiene

  • Single Use Only: Needles and syringes should be used once and disposed of immediately.

  • Consequences of Reuse: Needle breakage, clogging, inaccurate dosing, and lipohypertrophy.

  • Disposal: Use approved sharps containers; never resheathe (recap) needles.

3. Injection Technique

Preparation

  • Hand Washing: Always wash hands with soap and water; disinfect injection site if required (e.g., hospital setting) but let alcohol dry completely.

  • Cloudy Insulin (NPH/Premix): Gently roll 10 times and tip 10 times until milky white. Do not shake.

  • Priming: Always prime the pen (air shot) to ensure flow. Note: GLP-1 pens may only need priming once per first use (check manufacturer).

Insertion & Angle

  • 4-mm Needles: Inject at a 90-degree angle. A skin lift (pinch-up) is generally not required for adults but may be needed for very lean limbs/abdomens.

  • 6-mm Syringes/Needles:

    • 90-degree into a skin lift.

    • 45-degree may be required for lean individuals if no skin lift is used.

  • 8-mm Needles: Must use a skin lift and inject at 90 degrees. Lean patients should use a 45-degree angle with a skin lift.

The “Skin Lift” (Pinch-up)

  • Method: Lift skin and subcutaneous tissue delicately between thumb and index finger.

  • Avoid: Do not lift muscle. Do not squeeze so hard it causes blanching or pain.

Dwell Time

  • Count to 10: After the dose knob is fully depressed, hold the needle in place for a slow count of 10 seconds to ensure full dose delivery and prevent leakage.

4. Injection Sites & Rotation

Site Selection

  • Preferred Site: The abdomen is preferred for consistent absorption, especially for soluble (Regular) and NPH insulin.

  • Other Sites: Thighs (upper third anterior lateral) and Buttocks (posterior lateral upper).

  • The Arm: The arm is not a preferred site for self-injection due to difficulty ensuring a 90-degree angle and high risk of IM injection into the deltoid.

  • Avoid: Umbilicus (stay 2-3 cm away), moles, scars, and lipohypertrophy.

Rotation Strategy

  • Systematic Rotation: Essential to prevent lipohypertrophy.

  • Spacing: Injections should be spaced at least 1 to 2 cm (one finger width) apart.

  • Plan: Rotate sites within the same anatomical area (e.g., abdomen) at the same time of day to reduce glycemic variability.

5. Complications: Lipohypertrophy

  • Definition: “Rubbery” or thickened lesions in the fat tissue caused by insulin’s anabolic effect and needle reuse/lack of rotation.

  • Consequences:

    • erratic/blunted absorption (insulin pooling).

    • Unexplained hypoglycemia or hyperglycemia.

    • Increased insulin requirements (higher doses needed).

  • Detection: Visual inspection and palpation (sweeping motion with fingertips).

  • Management: Stop injecting into the area immediately. Use a new needle every time. Rotate sites.

    • Clinical Pearl: When switching from a lipo (rubbery) site to healthy tissue, reduce the insulin dose (often by ~20%) to prevent hypoglycemia, as absorption will suddenly improve.

6. Special Populations

Pregnancy

  • Preferred Site: Abdomen.

  • Third Trimester: Use the lateral sides of the abdomen (flanks) as the central skin becomes taut.

  • Needle: Use 4-mm needles to avoid fetal harm or IM injection.

Pediatrics

  • Needles: 4-mm is the safest length.

  • Technique:

    • Children >6 years: 4-mm at 90 degrees (no pinch usually needed).

    • Children 2-6 years: 4-mm with a skin lift.

  • Sites: Buttocks may be better for preschool children due to more fat tissue.

Older Adults

  • Considerations: Thinner skin, reduced dexterity, cognitive changes.

  • Device: Pens are preferred over syringes for safety and ease of use.

  • Cognitive Assessment: Use the Clock Drawing Test to assess ability to manage injection therapy.

7. Insulin Infusion (Pumps)

  • Change Frequency: Infusion sets should be changed every 2 to 3 days to prevent infection and lipohypertrophy.

  • Cannula Selection:

    • Teflon: Flexible, comfortable. Change every 2-3 days.

    • Steel: For those with Teflon allergies or kinking issues (e.g., pregnancy, high muscle mass). Change every 2 days.

  • Troubleshooting: “Unexplained hyperglycemia” = Check for occlusion/kinking. If ketones present, give insulin via pen/syringe immediately.

8. Storage & Handling

  • In-Use Insulin: Store at room temperature (max 25-30°C) to reduce injection pain and air bubbles.

    • Usually good for ~28 days (check manufacturer).

  • Unopened Insulin: Refrigerator (2 to 8°C). Do not freeze.

  • Extreme Temps: Avoid direct sunlight or temperatures >30°C.

Reference:

Berard L, Desrochers F, Husband A, MacNeil G, Roscoe R. FIT Canada Recommendations for Best Practice in Injection Technique – 4th Edition. Accessed June 8, 2025. http://www.fit4diabetes.com/canada-english/
Categories
CDE Diabetes

Flashcards: Clinical Practice Guidelines Tools & Resources

The 2018 Clinical Practice Guidelines provide a suite of practical tools designed to translate evidence into daily patient care. These flashcards are designed to help pharmacists and healthcare professionals memorize the critical acronyms, screening protocols, and safety checklists—from the “SADMANS” sick-day rules to the specific criteria for driving safety—ensuring you are ready for any clinical scenario.

Key Topics Covered:

  • Sick Day Management: Memorizing the “SADMANS” mnemonic to identify medications (Sulfonylureas, ACE inhibitors, Diuretics, Metformin, ARBs, NSAIDs, SGLT2 inhibitors) that must be paused during acute illness to prevent kidney injury.

  • Vascular Protection: Recalling the “ABCDES” checklist (A1C, BP, Cholesterol, Drugs, Exercise/Eating, Smoking/Stress) used in the Patient Care Flow Sheet to ensure comprehensive risk reduction.

  • Insulin Pharmacokinetics: Mastering the onset, peak, and duration profiles for various insulin types (rapid, short, intermediate, and long-acting) to optimize dosing and prevent hypoglycemia.

  • Neuropathy Screening: Reviewing the correct technique for using the 10g Semmes-Weinstein monofilament and 128 Hz tuning fork to detect loss of protective sensation.

  • Driving Safety: Understanding the specific assessment criteria for private vs. commercial drivers, including the requirements for glucose monitoring and hypoglycemia awareness.